Billionaire Profile
Rajeev Juneja
Global Rank
#1592

Image: Unsplash Contributor | Unsplash License | via Unsplash

Rajeev Juneja

CEO, Phamaceuticals
INDIA
Real-Time Net Worth
$2.649B
Estimated based on Phamaceuticals stock value as of April 20, 2026
+0.88% (24h)
Age
60
Source
Phamaceuticals
Industry
Healthcare
Citizenship
INDIA

Biography

Rajeev Juneja, the co-founder of Mankind Pharma, has built a significant net worth through the pharmaceuticals industry. His career began in 1984, and in 1995, he co-founded Mankind Pharma with his brother, Ramesh Juneja. Mankind Pharma is a major player in India's low-cost generics market, generating over $1.05 billion in revenue. Juneja's achievements include building a company recognized for affordable medicines, with popular brands such as Manforce condoms and Prega News. His strategic focus on expansion and innovation has driven the company to become a leading pharmaceutical entity in India.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life and Career Beginnings

Rajeev Juneja's journey began in India, where he was born around 1965. He co-founded Mankind Pharma in 1995 with his brother Ramesh Juneja. Juneja's early experiences involved working as a medical representative and gaining experience in the pharmaceutical industry.

Rise to Success with Mankind Pharma

In 1995, Rajeev Juneja and his brother Ramesh co-founded Mankind Pharma with the vision of providing affordable and high-quality medicines. The company initially focused on low-cost generics, a strategy that prioritized volume and accessibility in the Indian market. Mankind Pharma expanded its product portfolio to include consumer health products like condoms and pregnancy test kits, increasing revenue streams and brand recognition.

Key Business Strategies

Mankind Pharma's success is built on several key strategies. The company's emphasis on low-cost generics has allowed it to serve a large customer base, particularly in rural and semi-urban areas. The strategic decision to diversify into consumer health products has further expanded the company's revenue and brand recognition. Furthermore, Mankind Pharma went public in 2023, which has further solidified its position and attracted significant investor interest.

Philanthropy

While specific details on Rajeev Juneja’s philanthropy are not readily available, his commitment to Mankind Pharma’s mission suggests a broader interest in healthcare accessibility. Mankind Pharma's goal of providing affordable medicine points towards a focus on making a positive impact on society.

Career Milestones

1995

Co-founded Mankind Pharma

Co-founded Mankind Pharma with his brother Ramesh Juneja, which has grown into a major player in the Indian pharmaceutical market.

2023

Mankind Pharma IPO

Mankind Pharma went public, marking a significant milestone and further solidifying the company's position in the market.

2024

Appointed President of PHD Chamber of Commerce and Industry

Appointed President of the PHD Chamber of Commerce and Industry for the policy year 2025-26.

Philanthropy & Social Impact

Healthcare

Healthcare Initiatives

$XB

Mankind Pharma focuses on providing affordable and quality medicines to millions

Business Philosophy & Leadership

Leadership Principles

Visionary Approach

Known for his strategic acumen in the pharmaceutical industry.

Commitment to Affordable Healthcare

Dedicated to delivering high-quality pharmaceuticals and affordable medicines.

Fostering Economic Growth

Focused on promoting policy reforms that empower Indian businesses.